# Introduction

According to the requirements of 21 CFR 807.92, the following information provides sufficient detail to understand the basis for a determination of substantial equivalence.

The assigned 510(k) number is: K103747

# Submitter Address Phone number Fax number

SEPPIM S.A.S.   
Zone Industrielle, 61500 SEES, FRANCE + 33 (0)2 33 81 21 00   
+ 33 (0)2 33 28 77 51

# Contact

Valérie GOURDON (Email: v.gourdon@elitechgroup.com)

Date of Preparation

November, 23d, 2010

# Device names

# REAGENT :

Trade/proprietary Name: ELITech Clinical Systems CHOLESTEROL HDL SL 2G

Common or Usual Name:   
Device Class   
Classification name   
Product code   
High Density Lipoprotein (HDL) Cholesterol, "CHOLESTEROL HDL SL 2G"   
Class I,   
Lipoprotein test system (Sec.862.1475)   
LBS - LDL & VLDL Precipitation, Cholesterol Via Esterase-Oxidase,

# Predicate device

ABX PENTRA HDL Direct CP (K060854)

# Device description

The device for this submission is available as kit only. It consists of 2 reagents, "R1" and "R2".

Reagent R1 contains: Good's buffer, Cholesterol oxidase (CO bacterial), Peroxidase (horseradish), Ascorbate oxidase (bacterial), N,N-bis(4- sulphobutyl)-m-toluidine-disodium (DSBmT), Accelerator. Reagent R2 contains: Good's buffer, Cholesterol esterase (CHE bacterial). 4-Amino-Antipyrine (4-AA), detergent.

# Intended Use

ELITech Clinical Systems CHOLESTEROL HDL SL 2G is intended for use with ELITech Clinical Systems CHOLESTEROL HDL 2G CALIBRATOR and ELITech Clinical Systems ELITROL I and ELITROL II on ELITech Clinical Systems Selectra analyzers for the quantitative in vitro diagnostic determination of High Density Lipoprotein (HDL) Cholesterol in human serum and plasma. It is not intended for use in Point of Care settings.

# Indication(s) for Use

ELITech Clinical Systems_ CHOLESTEROL HDL SL 2G is intended to measure High Density Lipoprotein (HDL) Cholesterol in human serum and plasma. Lipoprotein measurements are used in the diagnosis and treatment of lipid disorders (such as diabetes mellitus), atherosclerosis, and various liver and renal diseases.

# Comparison to Predicate device

Page 5.2 of 5.13 pages   

<table><tr><td rowspan=1 colspan=1></td><td rowspan=1 colspan=1>ELITech Clinical Systems DeviceCHOLESTEROL HDL SL 2G</td><td rowspan=1 colspan=1>Predicate device(ABX PENTRA HDL Direct CP, K060854)</td></tr><tr><td rowspan=1 colspan=1>Intended use</td><td rowspan=1 colspan=1>Intended for use with ELITech ClinicalSystems CHOLESTEROL HDL 2GCALIBRATOR and ELITech ClinicalSystems ELITROL I and ELITROL 1I onELITech Clinical Systems Selectraanalyzers for the quantitative in vitrodiagnostic determination of HighDensity Lipoprotein HDL) Cholesterolin human serum and plasma. It is notintended for use in Point of Caresettings.</td><td rowspan=1 colspan=1>For quantitative in Vitro determination ofHigh-Density Lipoprotein Cholesterol(HDL-C) in human serum or plasma bycolorimetry.</td></tr><tr><td rowspan=1 colspan=1>Indication(s) for Use</td><td rowspan=1 colspan=1>Intended to measure High DensityLipoprotein(HDL) Cholesterolinhuman serum and plasma. Lipoproteinmeasurements are usedin thediagnosis and treatment of lipiddisorders (such as diabetes mellitus),atherosclerosis, and various liver andrenal diseases.</td><td rowspan=1 colspan=1>Intended to measure High DensityLipoprotein (HDL) Cholesterol in humanserum   and   plasma.   Lipoproteinmeasurements are used in the diagnosisand treatment of lipid disorders (such asdiabetes mellitus), atherosclerosis, andvarious liver and renal diseases.</td></tr><tr><td rowspan=1 colspan=1>Assay protocol</td><td rowspan=1 colspan=1>Enzymatic colorimetric test withaccelerator selective detergent</td><td rowspan=1 colspan=1>Enzymatic colorimetric test based onaccelerator Selective Detergent (withoutthe need for any off-line pretreatment orcentrifugation steps)</td></tr><tr><td rowspan=1 colspan=1>Composition</td><td rowspan=1 colspan=1>Reagent R1:Good&#x27;s buffer , pH 6.0;Cholesterol oxidase   &lt; 1000 U/L;Peroxidase             &lt; 1300 ppg U/L ;Ascorbate oxidase     &lt; 3000 U/L ;N,N-bis(4-sulphobutyl)-m-toluidine-disodium (DSBmT)    &lt; 1 mmol/L ;Accelerator            &lt; 1 mmol/LPreservative            &lt; 0.06 %Reagent R2:Good&#x27;s buffer, pH 6.0;Cholesterol esterase   &lt; 1500 U/L ;4-Amino-Antipyrine    &lt; 1 mmol/L;Detergent              &lt; 2%Preservative            &lt; 0.06 %</td><td rowspan=1 colspan=1>Reagent R1:Good&#x27;s bufferCholesterol oxidase    &lt; 1000 U/L ;Peroxidase             &lt; 1300 ppg U/L ;N.N-bis(4-sulphobutyl)-m-toluidine-disodium(DSBmT)              &lt; 1 mmol/L;Accelerator            &lt; 1 mmol/LPreservative            &lt; 0.06 %Reagent R2:Good&#x27;s bufferCholesterol esterase   &lt; 1500 U/L ;4-Amino-Antipyrine    &lt; 1 mmol/L;Detergent              &lt; 2%Restrainer              &lt; 0.15 %Preservative             &lt; 0.06 %Ascorbic acid oxidase   &lt; 3000 U/L</td></tr><tr><td rowspan=1 colspan=1>Appearance of reagent</td><td rowspan=1 colspan=1>Liquid form, ready to use</td><td rowspan=1 colspan=1>Same</td></tr><tr><td rowspan=1 colspan=1>Sample type</td><td rowspan=1 colspan=1>SerumPlasma in lithium heparin</td><td rowspan=1 colspan=1>SerumPlasma in lithium heparin</td></tr><tr><td rowspan=1 colspan=1>Reagent storage</td><td rowspan=1 colspan=1>Store at 2-8 °C and protected from</td><td rowspan=1 colspan=1>Reagents, in unopened cassette, are</td></tr></table>

<table><tr><td colspan="4"></td></tr><tr><td rowspan="2"></td><td colspan="2">ELITech Clinical Systems Device CHOLESTEROL HDL SL 2G</td><td>Predicate device (ABX PENTRA HDL Direct CP, K060854)</td></tr><tr><td colspan="2">light. The reagents are stable until the</td><td>stable up to expiry date on the label if</td></tr><tr><td>Expected values</td><td colspan="2">expiry date stated on the label. According to NCEP classification according to the risk of developping</td><td>stored at 2-8 C. According to NCEP classification according to the risk of developping</td></tr><tr><td></td><td colspan="2">coronary heart disease High : &lt; 40 mg/dL Low: ≥ 60 mg/dL</td><td>coronary heart disease High : &lt; 40 mg/dL Low: ≥ 60 mg/dL</td></tr><tr><td>Instrument</td><td colspan="2">SELECTRA JUNIOR</td><td>ABX PENTRA 400</td></tr><tr><td>Measuring range</td><td colspan="2">5 to 105 mg/dL</td><td>5.4 to 151.9 mg/dL</td></tr><tr><td>Limit of detection (LoD) Limit of quantification</td><td colspan="2">0.7 mg/dL 5.0 mg/dL</td><td>1.16 mg/dL</td></tr><tr><td>(LoQ) Precision</td><td colspan="2">Within run</td><td>Within run</td></tr><tr><td></td><td colspan="2">Level 31 mg/dL CV=1.4% Level 56 mg/dL CV=0.7% y=1.09x - 2.5 mg/dL $^{= 0.972</td><td>Level 35.82 mg/dL CV=1.29% Level 81.72 mg/dLCV=0.79%</td></tr><tr><td rowspan="8"></td><td colspan="2">Total</td><td>Level 27.94 mg/dL CV=1.32%</td></tr><tr><td colspan="2">Level 87 mg/dL CV=1.4%</td><td>Level 48.59 mg/dL CV=1.91%</td></tr><tr><td colspan="2"></td><td>Level 97.39 mg/dL CV=0.62%</td></tr><tr><td colspan="2"></td><td></td></tr><tr><td colspan="2">CV=3.0%</td><td>Total</td></tr><tr><td colspan="2">Level 31 mg/dL Level 56 mg/dL CV=2.8%</td><td>Level 35.85 mg/dL CV=2.88%</td></tr><tr><td colspan="2">CV=3.3% Level 87 mg/dL</td><td>Level 80.35 mg/dL CV=3.06% Level 47.07 mg/dL CV=3.52%</td></tr><tr><td colspan="2"></td><td>Level 80.16 mg/dL CV=2.69%</td></tr><tr><td colspan="2">Method comparison Limitations</td><td colspan="2">y=0.91x + 1.98 mg/dL $^{}.9768</td></tr><tr><td rowspan="4"></td><td colspan="2">range: 5 to 105 mg/dL following components :</td><td>range: 5.4 to 151.9 mg/dL</td></tr><tr><td colspan="2">No significant interference for the</td><td>Hemoglobin: No significant influence is</td></tr><tr><td colspan="2">Unconjugated bilirubin (up to 30 mg/dL) Conjugated bilirubin (up to 29.5 mg/dL) Hemoglobin (up to 500 mg/dL) observed up to 11.7 mg/dL.</td><td>observed up to 479 mg/dL. Triglycerides: No significant influence is observed up to 612.5 mg/dL. Total bilirubin: No significant influence is</td></tr><tr><td colspan="3">Turbidity : Negative bias from 439 Direct bilirubin: No significant influence mg/dL triglycerides equivalent. is observed up to 28.1 mg/dL.</td></tr><tr><td rowspan="2">On board stability Calibrator</td><td colspan="2">refrigerated area : 28 days</td><td>refrigerated area: 31 days</td></tr><tr><td colspan="2">Recommended calibration material (not included):</td><td>Recommended calibration material (not included):</td></tr><tr><td colspan="2"></td><td>ELITech Clinical Systems Cholesterol HDL 2G Calibrator</td><td>ABX Pentra HDL Cal</td></tr></table>

Conclusion   

<table><tr><td></td><td>ELITech Clinical Systems Device</td><td>Predicate device</td></tr><tr><td rowspan="2">Controls</td><td rowspan="2">CHOLESTEROL HDL SL 2G Recommended quality control material</td><td>(ABX PENTRA HDL Direct CP, K060854)</td></tr><tr><td>Recommended quality control material (not included):</td></tr><tr><td rowspan="4"></td><td>(not included): ELITech Clinical Systems Elitrol I (Normal control)</td><td>ABX Pentra N Control</td></tr><tr><td></td><td>(Normal control)</td></tr><tr><td>ELITech Clinical Systems Elitrol II</td><td></td></tr><tr><td>(Pathologic control)</td><td>ABX Pentra P Control (Pathologic control)</td></tr></table>

The performance data and other information demonstrate that the safety and effectiveness of this device versus the predicate device is not compromised, and that it met all acceptance criteria, demonstrating that the device is substantially equivalent to its respective predicate device.

# SECTION 5 - 510(k) Summary - ELITech Clinical Systems CHOLESTEROL HDL 2G CALIBRATOR

# Introduction

According to the requirements of 21 CFR 807.92, the following information provides sufficient detail to understand the basis for a determination of substantial equivalence.

The assigned $5 1 0 ( \mathsf { k } )$ number is: K103747

# Submitter Address Phone number Fax number

SEPPIM S.A.S.   
Zone Industrielle, 61500 SEES, FRANCE + 33 (0)2 33 81 21 00   
+ 33 (0)2 33 28 77 51

# Contact

Valérie GOURDON (Email: v.gourdon@elitechgroup.com)

Date of Preparation

November, $2 3 ^ { \mathsf { r d } }$ ,2010

# Device names

Trade/proprietary Name   
Common or Usual Name   
Device Class   
Classification name   
Product code   
ELITech Clinical Systems CHOLESTEROL HDL 2G CALIBRATOR   
Calibrator "CHOLESTEROL HDL 2G CALIBRATOR"   
Class II   
Calibrator (Sec.862.1150)   
JIS- Calibrator, Primary

# Predicate device

Ultra N-Geneous HDL Calibrator from Genzyme (K021316)

# Device description

ELITech Clinical Systems CHOLESTEROL HDL 2G CALIBRATOR is a lyophilized calibrator based on human serum containing lipoprotein from the various lipoprotein classes including high density lipoproteins and sodium azide as preservative.

CHOLESTEROL HDL 2G CALIBRATOR is prepared exclusively from the blood of donors tested individually and found to be negative for HbsAg and to antibodies to HCV and HIV according to FDA-approved methods.

# Intended Use

ELITech Clinical Systems CHOLESTEROL HDL 2G CALIBRATOR is a calibrator for in vitro diagnostic use in the calibration of quantitative ELiTech Clinical Systems CHOLESTEROL HDL SL 2G on ELITech Clinical Systems Selectra analyzers.

# Comparison to Predicate device

<table><tr><td rowspan=1 colspan=1></td><td rowspan=1 colspan=1>ELITech Clinical Systems Device(CHOLESTEROL HDL 2G CALIBRATOR)</td><td rowspan=1 colspan=1>Predicate device(Genzyme Ultra N-GeneousCHOLESTEROL HDL Calibrator )</td></tr><tr><td rowspan=1 colspan=1>Intended use</td><td rowspan=1 colspan=1>For in vitro diagnostic use in thecalibration of quantitative ELITech ClinicalSystems CHOLESTEROL HDL SL 2G onELITech Clinical Systems Selectraanalyzers.</td><td rowspan=1 colspan=1>For the calibration of Ultra N-GenousHDL Cholesterol</td></tr><tr><td rowspan=1 colspan=1>Format</td><td rowspan=1 colspan=1>Lyophilized calibrator based on humanserum onhuman serum containinglipoprotein from the variouslipoproteinclasses   including    high    densitylipoproteins. This calibrator containssodium azide as preservative.</td><td rowspan=1 colspan=1>Lyophilized calibrator based on humanserum on human serum containinglipoprotein from the various lipoproteinclasses   including   high   densitylipoproteins. This calibratorcontainssodium azide as preservative.</td></tr><tr><td rowspan=1 colspan=1>Level</td><td rowspan=1 colspan=1>Single level</td><td rowspan=1 colspan=1>Single level</td></tr><tr><td rowspan=1 colspan=1>Handling</td><td rowspan=1 colspan=1>Carefully open the vial, avoiding the lossof lyophilizate, and pipette in exactly 1 mLof distilled/deionized water. Carefullyclose the vial and dissolve the content bysuccessive swirling. Wait for around 20minutes until the complete dissolution andhomogenize again. Do not shake stronglyto avoid formation of foam.</td><td rowspan=1 colspan=1>Carefully open the vial, avoiding the lossof lyophilizate, and reconstitute with 1mL of deionized water. Close the vialand let stand for 20 minutes. Dissolvethe contents of the vial by swirling gentlyto avoid the formation of foam. Do notshake.</td></tr><tr><td rowspan=1 colspan=1>Stability</td><td rowspan=1 colspan=1>Lyophilized:To store at 2-8 °C and protected from lightuntil the expiry dateAfter reconstitution, the stabilities are :- 14 days between 2 - 8 °C.- 4 weeks at less than - 80 °C (whenfrozen once)</td><td rowspan=1 colspan=1>Lyophilized:To store at 2-8 C and protected fromlight until the expiry dateAfter reconstitution, the stabilities are :- 14 days between 2 - 8 °C.- 4 weeks between -70 °C (when frozenonce)</td></tr></table>

# Conclusion

The performance data and other information demonstrate that the safety and effectiveness of this device versus the predicate device is not compromised, and that it met all acceptance criteria, demonstrating that the device is substantially equivalent to its respective predicate device.

# SECTION 5 - 510(k) Summary ELITech Clinical Systems CHOLESTEROL LDL SL 2G

# Introduction

According to the requirements of 21 CFR 807.92, the following information provides sufficient detail to understand the basis for a determination of substantial equivalence.

The assigned 510(k) number is: K103747

Submitter Address Phone number Fax number

SEPPIM S.A.S.   
Zone Industrielle, 61500 SEES, FRANCE + 33 (0)2 33 81 21 00   
+ 33 (0)2 33 28 77 51

# Contact

Valérie GOURDON (Email: v.gourdon@elitechgroup.com)

Date of Preparation

November, 23, 2010

# Device names

# REAGENT :

Trade/proprietary Name: ELITech Clinical Systems CHOLESTEROL LDL SL 2G

Common or Usual Name:   
Device Class   
Classification name   
Product code   
Low Density Lipoprotein (LDL) Cholesterol, "CHOLESTEROL HDL SL 2G"   
Class I   
Lipoprotein test system (Sec.862.1475)   
LBS - LDL & VLDL Precipitation, Cholesterol Via Esterase

# Predicate device

ABX PENTRA LDL Direct CP (K060854)

# Device description

The device for this submission is available as kit only. It consists of 2 reagents, "R1" and "R2".

Reagent R1 contains: MES buffer, Detergent 1, Cholesterol esterase (CHE bacterial), Cholesterol oxidase (CO bacterial), Peroxidase (horseradish), 4- Amino-Antipyrine (4-AA), Ascorbate oxidase (vegetal).   
Reagent R2 contains: MES buffer, Detergent 2, N,N-bis(4-sulphobutyl) $m$ - toluidine-disodium (DSBmT).

# Intended Use

ELITech Clinical Systems CHOLESTEROL LDL SL 2G is intended for use with ELITech Clinical Systems CHOLESTEROL LDL 2G CALIBRATOR and ELITech Clinical Systems ELITROL I and ELITROL II for the quantitative in vitro diagnostic determination of Low Density Lipoprotein (LDL) Cholesterol in human serum and plasma on ELITech Clinical Systems Selectra analyzers. It is not intended for use in Point of Care settings.

Indication(s) for Use

ELITech Clinical Systems CHOLESTEROL LDL SL 2G is intended to measure Low Density Lipoprotein (LDL) Cholesterol in human serum and plasma. Lipoprotein measurements are used in the diagnosis and treatment of lipid disorders (such as diabetes mellitus), atherosclerosis, and various liver and renal diseases.

# Comparison to Predicate device

<table><tr><td colspan="1" rowspan="1"></td><td colspan="1" rowspan="1">ELI Tech Clinical Systems DeviceCHOLESTEROL LDL SL 2G</td><td colspan="1" rowspan="1">Predicate device(ABX PENTRA LDL DIRECT CP)</td></tr><tr><td colspan="1" rowspan="1">Intended use</td><td colspan="1" rowspan="1">Intended for use with ELITechClinical Systems CHOLESTEROLLDL 2G CALIBRATOR andELITech Clinical Systems ELITROLI and ELITROL II for thequantitative in vitro diagnosticdetermination of Low DensityLipoprotein (LDL) Cholesterol inhuman serum and plasma onELITech Clinical Systems Selectraanalyzers. It is not intended for usein Point of Care settings.</td><td colspan="1" rowspan="1">For    quantitative    in   vitrodetermination of Low DensityLipoprotein Cholesterol (LDL-C) inserum or plasma by colorimetry.</td></tr><tr><td colspan="1" rowspan="1">Indication(s) for Use</td><td colspan="1" rowspan="1">Intended to measure Low DensityLipoprotein (LDL) Cholesterol inhuman  serum andplasma.Lipoprotein measurementsareused in the diagnosis and treatmentof lipid disorders (such as diabetesmellitus),atherosclerosis,  andvarious liver and renal diseases.</td><td colspan="1" rowspan="1">Intended to measure Low DensityLipoprotein (LDL) Cholesterol inhuman serum and plasma. Lipopro-tein measurements are used in thediagnosis and treatment of lipiddisorders (such as diabetes melli-tus), atherosclerosis, and variousliver and renal diseases.</td></tr><tr><td colspan="1" rowspan="1">Assay protocol</td><td colspan="1" rowspan="1">Enzymatic colorimetric test withselective detergent</td><td colspan="1" rowspan="1">Enzymatic colorimetric test withselective detergent</td></tr><tr><td colspan="1" rowspan="1">Composition</td><td colspan="1" rowspan="1">Reagent R1:MES buffer , pH 6.3;Detergent 1          &lt; 1.0 %,Cholesterol esterase&lt; 1500 U/L,Cholesterol oxidase &lt; 1500 U/L;Peroxidase           &lt; 1300 ppg U/L;4-Amino-Antipyrine   &lt; 0.1 %,Ascorbate oxidase   &lt; 3000 U/LPreservativeReagent R2:MES buffer, pH 6.3;Detergent 2             &lt; 1.0 %,N,N-bis(4-sulphobutyl)-m-toluidine-disodium        &lt; 1 mmol/LPreservative</td><td colspan="1" rowspan="1">Reagent R1:MES buffer pH 6.3;Detergent 1          &lt; 1.0 %,Cholesterol esterase&lt; 1500 U/L,Cholesterol oxidase &lt; 1500 U/L;Peroxidase          &lt; 1300 ppg U/L;4-Amino-Antipyrine   &lt; 0.1 %,Ascorbate oxidase   &lt; 3000 U/LPreservativeReagent R2:MES buffer, pH 6.3;Detergent 2             &lt; 1.0 %,N.N-bis(4-sulphobutyl)-m-toluidine-disodium        &lt; 1 mmol/LPreservative</td></tr><tr><td colspan="1" rowspan="1">Appearance of reagent</td><td colspan="1" rowspan="1">Liquid form, ready to use</td><td colspan="1" rowspan="1">Same</td></tr><tr><td colspan="1" rowspan="1">Sample type</td><td colspan="1" rowspan="1">SerumPlasma in lithium heparin</td><td colspan="1" rowspan="1">SerumPlasma in lithium heparin</td></tr><tr><td colspan="1" rowspan="1">Reagent storage</td><td colspan="1" rowspan="1">Store at 2-8 C and protected fromlight. The reagent is stable until theexpiry date stated on the label.</td><td colspan="1" rowspan="1">Reagents, in unopened cassette,are stable up to expiry date on thelabel if stored at 2-8 C.</td></tr><tr><td colspan="1" rowspan="1">Expected values</td><td colspan="1" rowspan="1">According to NCEP, classificationaccording to the risk of developingcoronary heart disease:Optimal :            &lt; 100 mg/dLNear or above optimal: 100-129 mg/dLBorderline High :     130-159 mg/dLHigh:                 160-189 mg/dLVery high :           ≥ 190 mg/dL</td><td colspan="1" rowspan="1">Following NCEP cutpoints forpatient classification are used forthe prevention and management ofcoronary artery disease:Desirable :       &lt; 130mg/dLBorderline High risk: 130 -159 mg/dLHigh risk :       160   mg/dL</td></tr><tr><td colspan="1" rowspan="1"></td><td colspan="1" rowspan="1">ELITech Clinical Systems DeviceCHOLESTEROL LDL SL 2G</td><td colspan="1" rowspan="1">Predicate device(ABX PENTRA LDL DIRECT CP)</td></tr><tr><td colspan="1" rowspan="1">Instrument</td><td colspan="1" rowspan="1">Vital Scientific SELECTRA JUNIOR</td><td colspan="1" rowspan="1">ABX PENTRA 400</td></tr><tr><td colspan="1" rowspan="1">Measuring range</td><td colspan="1" rowspan="1">15 to 380 mg/dL</td><td colspan="1" rowspan="1">1.35 to 369.39 mg/dL</td></tr><tr><td colspan="1" rowspan="1">Limit of Detection (LoD)</td><td colspan="1" rowspan="1">0.3 mg/dL</td><td colspan="1" rowspan="2">1.55 mg/dL</td></tr><tr><td colspan="1" rowspan="1">Limit of Quantification (LoQ)</td><td colspan="1" rowspan="1">10.0 mg/dL</td></tr><tr><td colspan="1" rowspan="1">Precision</td><td colspan="1" rowspan="1">Within runLevel 108 mg/dLCV=1.4%Level122 mg/dLCV=1.3%Level162 mg/dLCV=2.0%TotalLevel108 mg/dLCV=2.6%Level122 mg/dLCV=2.7%Level162 mg/dLCV=4.0%</td><td colspan="1" rowspan="1">Within runLevel 61.26 mg/dL   CV=1.01%Level75.08 mg/dL   CV=2.82%Level111.26 mg/dL CV=0.91%Level141.45 mg/dL CV=1.00%Level191.16 mg/dL CV=0.63%TotalLevel60.64 mg/dL   CV=5.59%Level74.27 mg/dL   CV=6.39%Level156.58 mg/dL  CV=3.94%Level191.62 mg/dL CV=4.04%</td></tr><tr><td colspan="1" rowspan="1">Method comparison</td><td colspan="1" rowspan="1">y= 0.999 x - 0.5 mg/dL$^{2}0.93range: 16-378 mg/dL</td><td colspan="1" rowspan="1">y=0.96x - 0.21 mg/dL2= 0.9963range: 1.35 to 369.39 mg/dL</td></tr><tr><td colspan="1" rowspan="1">Limitations</td><td colspan="1" rowspan="1">Hemoglobin:   No   significantinterference up to 500 mg/dL.Turbidity:      No     significantinterference up to 614 mg/dLtriglycerides equivalent.Unconjugated   bilirubin:   Nosignificant interference up to 30mg/dL.Conjugated    bilirubin:    Nosignificant interference up to 29.5mg/dL.</td><td colspan="1" rowspan="1">Hemoglobin: No significantinfluence is observed up to 460mg/dL.Triglycerides: No significantinfluence is observed up to 613mg/dL.Total bilirubin: No significantinfluence is observed up to 8.19mg/dL.Direct bilirubin: No significantinfluence is observed up to 5.63mg/dL.</td></tr><tr><td colspan="1" rowspan="1">Calibration Frequency</td><td colspan="1" rowspan="1">28 days</td><td colspan="1" rowspan="1">14 days</td></tr><tr><td colspan="1" rowspan="1">On board stability</td><td colspan="1" rowspan="1">refrigerated area : 28 days</td><td colspan="1" rowspan="1">refrigerated area: 97 days</td></tr><tr><td colspan="1" rowspan="1">Calibrator</td><td colspan="1" rowspan="1">Recommended calibration material(not included):ELITech Clinical SystemsCholesterol LDL 2G Calibrator</td><td colspan="1" rowspan="1">Recommended calibration material(not included):ABX Pentra LDL Cal</td></tr><tr><td colspan="1" rowspan="1">Controls</td><td colspan="1" rowspan="1">Recommended quality controlmaterial (not included):ELITech Clinical Systems Elitrol I(Normal control)ELITech Clinical Systems Elitrol II(Pathologic control)</td><td colspan="1" rowspan="1">Recommended quality controlmaterial (not included):ABX Pentra N Control(Normal control)ABX Pentra P Control (Pathologiccontrol</td></tr></table>

# Conclusion

The performance data and other information demonstrate that the safety and effectiveness of this device versus the predicate device is not compromised, and that it met all acceptance criteria, demonstrating that the device is substantially equivalent to its respective predicate device.

# SECTION 5 - 510(k) Summary - ELITech Clinical Systems CHOLESTEROL LDL 2G CALIBRATOR

# Introduction

According to the requirements of 21 CFR 807.92, the following information provides sufficient detail to understand the basis for a determination of substantial equivalence.

The assigned 510(k) number is: K103747

Submitter Address Phone number Fax number

SEPPIM S.A.S.   
Zone Industrielle, 61500 SEES, FRANCE + 33 (0)2 33 81 21 00   
+ 33 (0)2 33 28 77 51

Contact

Valérie GOURDON (Email: v.gourdon@elitechgroup.com)

Date of Preparation November, $2 3 ^ { \mathsf { r d } }$ ,2010

Trade/proprietary Name: ELITech Clinical Systems CHOLESTEROL LDL 2G CALIBRATOR   
Common or Usual Name:Calibrator "CHOLESTEROL LDL 2G CALIBRATOR"   
Device Class Class II   
Classification name Calibrator (Sec.862.1150)   
Product code JIS- Calibrator, Primary

# Predicate device

N-geneous LDL Calibrator from Genzyme (K971573)

# Device description

ELITech Clinical Systems CHOLESTEROL LDL 2GCALIBRATOR is lyophilized calibrator based on human serum containing lipoprotein from th various lipoprotein classes including low density lipoproteins and sodium azide as preservative.

CHOLESTEROL LDL 2G CALIBRATOR is prepared from plasma donor units tested individually by FDA - approved methods and found to be negative for HbsAg, anti-HCV antibody and anti-HIV1&2 antibodies.

# Intended Use

ELITech Clinical Systems CHOLESTEROL LDL 2G CALIBRATOR intended for use with ELITech Clinical Systems CHOLESTEROL LDL 2G CALIBRATOR and ELITech Clinical Systems ELITROL I and ELITROL II for the quantitative in vitro diagnostic determination of Low Density Lipoprotein (LDL) Cholesterol in human serum and plasma on ELITech Clinical Systems Selectra analyzers. It is not intended for use in Point of Care settings.

# Comparison to Predicate device

<table><tr><td rowspan=1 colspan=1></td><td rowspan=1 colspan=1>ELITech Clinical Systems Device(CHOLESTEROL LDL 2GCALIBRATOR)</td><td rowspan=1 colspan=1>Predicate device(Genzyme N-geneous LDLCholesterol Calibrator)</td></tr><tr><td rowspan=1 colspan=1>Intended use•</td><td rowspan=1 colspan=1>For in vitro diagnostic use in thecalibration of quantitative ELITechClinical Systems CHOLESTEROLLDL SL 2G on ELITech ClinicalSystems Selectra analyzers.</td><td rowspan=1 colspan=1>For the calibration of Ultra N-Genous LDL Cholesterol assay inserum or plasma.</td></tr><tr><td rowspan=1 colspan=1>Format</td><td rowspan=1 colspan=1>Lyophilized calibrator based onhuman serum on human serumcontaininglipoprotein from thevarious    lipoprotein    classesincluding low density lipoproteins.This calibrator contains sodiumazide as preservative.</td><td rowspan=1 colspan=1>Lyophilizedcalibratorbasedonhuman serum on human serumcontaininglipoproteinfrom thevarious    lipoprotein     classesincluding low density lipoproteins.This calibrator contains sodiumazide as preservative</td></tr><tr><td rowspan=1 colspan=1>Level</td><td rowspan=1 colspan=1>Single level</td><td rowspan=1 colspan=1>Single level</td></tr><tr><td rowspan=1 colspan=1>Handling</td><td rowspan=1 colspan=1>Carefully open the vial, avoiding theloss of lyophilizate, and pipette inexactly 1 mL of distilled/deionizedwater. Carefully close the vial anddissolve the content by successiveswirling. Wait for around 5 minutesuntil the complete dissolution andhomogenize again. Do not shakestrongly to avoid formation of foam.</td><td rowspan=1 colspan=1>Reconstitute by adding 1 mL ofdistilled or deionized water. Closethe vial and let stand for 5 minutes.Dissolve the contents of the vial byswirling gently to avoid theformation of foam. Do not shake.</td></tr><tr><td rowspan=1 colspan=1>Stability</td><td rowspan=1 colspan=1>Lyophilized:To store at 2-8 °C and protectedfrom light until the expiry dateAfter reconstitution, the stabilitiesare :- 14 days between 2 - 8 C.- 4 weeks at less than -80 °(frozen only once)</td><td rowspan=1 colspan=1>Lyophilized:To store at 2-8 °C and protectedfrom light until the expiry dateAfter reconstitution, the stabilitiesare :- 2 weeks at 2 - 8 °C.- the reconstituted calibrator may bealiquoted and stored at -80 C.</td></tr></table>

# Conclusion

The performance data and other information demonstrate that the safety and effectiveness of this device versus the predicate device is not compromised, and that it met all acceptance criteria, demonstrating that the device is substantially equivalent to its respective predicate device.

# SECTION 5 - 510(k) Summary = ELITech Clinical Systems ELITROL I and ELITROL II

# Introduction

According to the requirements of 21 CFR 807.92, the following information provides sufficient detail to understand the basis for a determination of substantial equivalence.

The assigned 510(k) number is: K103747

# Submitter Address Phone number Fax number

SEPPIM S.A.S.   
Zone Industrielle, 61500 SEES, FRANCE + 33 (0)2 33 81 21 00   
+ 33 (0)2 33 28 77 51

# Contact

Valérie GOURDON (Email: v.gourdon@elitechgroup.com)

Date of Preparation November, $2 3 ^ { \prime { \mathsf { d } } }$ ,2010

# Device names

CONTROLS:   
Trade/proprietary Name:   
Common or Usual Name:   
Device Class   
Classification name ELITech Clinical Systems ELITROL I and ELITROL II Multi-analyte controls  all kinds, "ELITROL I"ELITROL II Class 1   
Quality control material (assayed and unassayed).(21 CFR 862.1660)   
JJX- Multi-analyte controls - all kinds

Product code

# Predicate device

Roche Diagnostics Precinorm U (K041227) Roche Diagnostics Precipath U (K041227)

# Device description

ELITech Clinical Systems ELITROL I and ELITROL II are two level quality control products consisting of lyophilized human serum containing constituents at desired levels.

Elitrol I and Elitrol I are prepared exclusively from the blood of donors tested individually and found to be negative for HbsAg and to antibodies to HCV and HIV according to FDA-approved methods or methods in compliance with the European Directive 98/79/EC, Annex 1I, List A.

# Intended Use

ELITech Clinical Systems ELITROL I & ELITROL II are multi-parametric control sera for in vitro diagnostic use in quality control of quantitative ELITech Clinical Systems methods on ELITech Clinical Systems Selectra analyzers.

# Comparison to Predicate device

<table><tr><td rowspan=1 colspan=1></td><td rowspan=1 colspan=1>ELITech Clinical Systems DeviceELITROL |/ ELITROL II</td><td rowspan=1 colspan=1>Predicate DeviceRoche Precinorm U / Precipath U</td></tr><tr><td rowspan=1 colspan=1>Intended use</td><td rowspan=1 colspan=1>ELITech Clinical Systems ELITROLI &amp; ELITROL II are multi-parametriccontrol sera for in vitro diagnosticuse in quality control of quantitativeELITech Clinical Systems methodson ELITech  Clinical  SystemsSelectra analyzers.</td><td rowspan=1 colspan=1>For in vitro diagnostic use in qualitycontrol by monitoring accuracy andprecision for the quantitativemethods as specified in the valuesheet</td></tr><tr><td rowspan=1 colspan=1>Format</td><td rowspan=1 colspan=1>Lyophilized human sera withconstituents added as required toobtain desired components levels</td><td rowspan=1 colspan=1>Lyophilized human sera withconstituents added as required toobtain desired components levels</td></tr><tr><td rowspan=1 colspan=1>Levels</td><td rowspan=1 colspan=1>Two levels</td><td rowspan=1 colspan=1>Two levels</td></tr><tr><td rowspan=1 colspan=1>Handling</td><td rowspan=1 colspan=1>Carefully open the vial, avoiding theloss of lyophilate, and pipette inexactly 5 mL of distilled/deionizedwater. Carefully close the vial anddissolve the contents completely byoccasional gentle swirling within 30minutes avoiding the formation offoam.</td><td rowspan=1 colspan=1>Carefully open the bottle, avoidingthe loss of lyophilate, and pipette inexactly 5 mL of distilled/deionizedwater. Carefully close the bottle anddissolve the contents completely byoccasional gentle swirling within 30minutes. Avoid the formation offoam.</td></tr><tr><td rowspan=1 colspan=1>Stability</td><td rowspan=1 colspan=1>Lyophilized:To store at 2-8°C and protectedfrom light until the expiry date.After reconstitution, the stabilitiesare :- 12 hours between 15-25 °C.- 5 days between 2-8 C.- 4 weeks between -25 and -15 (when frozen once)</td><td rowspan=1 colspan=1>Lyophilized:Stable at 2-8°C up to expirationdate.After reconstitution, the stabilities*are :- 12 hours at 15-25 C.- 5 days at 2-8 C.- 4 weeks at (-25)-(-15) °C (whenfrozen once)*Exception for bilirubin total &amp; directas noted in package insert</td></tr></table>

# Conclusion

The performance data and other information demonstrate that the safety and effectiveness of these devices versus the predicate devices are not compromised, and that it met all acceptance criteria, demonstrating that the device is substantially equivalent to its respective predicate device.

# Re: k103747

Trade/Device Name: ELITech Clinical Systems CHOLESTEROL HDL SL 2G, ELITech Clinical Systems CHOLESTEROL HDL 2G CALIBRATOR, ELITech Clinical Systems CHOLESTEROL LDL SL 2G, ELITech Clinical Systems CHOLESTEROL LDL 2G CALIBRATOR, and ELITech Clinical Systems ELITROL I and ELITROL II   
Regulation Number: 21 CFR 862.1475   
Regulation Name: LDL & VLDL Precipitation, Cholesterol Via Esterase-Oxidase, HDL   
Regulatory Class: Class l, meets limitations per 21 CFR 862.9(c)(4)   
Product Codes: LBS, JIT, JY, MRR   
Dated: August 25, 2011   
Received: August 30, 2011

Dear Ms. Hutson:

We have reviewed your Section 510(k) premarket notification of intent to market the device referenced above and have determined the device is substantially equivalent (for the indications for use stated in the enclosure) to legally marketed predicate devices marketed in interstate commerce prior to May 28, 1976, the enactment date of the Medical Device Amendments, or to devices that have been reclassified in accordance with the provisions of the Federal Food, Drug, and Cosmetic Act (Act) that do not require approval of a premarket approval application (PMA). You may, therefore, market the device, subject to the general controls provisions of the Act. The general controls provisions of the Act include requirements for annual registration, listing of devices, good manufacturing practice, labeling, and prohibitions against misbranding and adulteration.

If your device is classified (see above) into class II (Special Controls), it may be subject to such additional controls. Existing major regulations affecting your device can be found in Title 21. Code of Federal Regulations (CFR), Parts 800 to 895. In addition, FDA may publish further announcements concerning your device in the Federal Register.

Please be advised that FDA's issuance of a substantial equivalence determination does not mean that FDA has made a determination that your device complies with other requirements of the Act or any Federal statutes and regulations administered by other Federal agencies. You must comply with all the Act's requirements, including, but not limited to: registration and listing (21 CFR Part 807); labeling (21 CFR Parts 801 and 809); medical device reporting (reporting of medical device-related adverse events) (21 CFR 803); and good manufacturing practice requirements as set forth in the quality systems (QS) regulation (21 CFR Par1 820). This letter

Page 2 -

If you desie speciic advice for your device on ur labeling regulation (21 CFR Part 801), please contact the Office of /n Virro Diagnostic Device.Evaluation and Safety at (301) 796-5450. Also, please note the regulation entiled, "Misbranding by reference to premarket notification" (21 CFR Part 807.97). For questions regarding postmarket surveillance, please contact CDRH's Office of Surveillance and Biometric's ('s) Division of Postmarket Surveillance at (301) 796-5760. For questions regarding the reporting of adverse events under the MDR regulation (21 CFR Part 803), please go to   
http://www.fda.gov/MedicalDevices/Safety/ReportaProblem/default.htm for the CDRH's Office of Surveillance and Biometrics/Division of Postmarket Surveillance.

You may obtain other general information on your responsibilities under the Act from the Division of Small Manufacturers, International and Consumer Assistance at its to-ree number (800) 638-2041r (30179- 5680 or at its Internet address htp://www.fda.gov/MedicalDevices/ResourcesforYou/Industry/default.htm.

Sincerely yours,

![](images/baee2c38ae41fc25490fa61673896e2f384def810cce1537e856158976598848.jpg)

Courtney H. Lias, Ph.D.   
Director   
Division of Chemistry and Toxicology   
Office of In Vitro Diagnostic Device   
Evaluation and Safety   
Center for Devices and Radiological Health

# Indications for Use Form

510(k) Number (if known): _ K103747

Device Name: ELITech Clinical Systems CHOLESTEROL HDL SL 2G ELITech Clinical Systems CHOLESTEROL HDL 2G CALIBRATOR

Indications for Use:

# Reagent:

ELITech Clinical Systems CHOLESTEROL HDL SL 2G is intended for use with ELITech Clinical Systems CHOLESTEROL HDL 2G CALIBRATOR and ELITech Clinical Systems ELITROL I and ELITROL II on ELITech Clinical Systems Selectra analyzers for the quantitative in vitro diagnostic determination of High Density Lipoprotein (HDL) Cholesterol inhuman serum and plasma. It isot intended or usen Point o a settings.

Lipoprotein measurements are used in the diagnosis and treatment of lipid disorders (such as diabetes mellitus), atherosclerosis, and various liver and renal diseases.

# Calibrator

ELITech Clinical Systems CHOLESTEROL HDL 2G CALIBRATOR is a calibrator for in vitro diagnostic use in the calibration of quantitative ELITech Clinical Systems CHOLESTEROL HDL SL 2G on the ELITech Clinical Systems Selectra analyzers.

Pascription Ue u D AND/OR (ver-The-Counteruse)

(PLEASE DO NOT WRITE BELOW THIS LINE-CONTINUE ON ANOTHER PAGE OF NEEDED)

Concurence of CDRH, Office of In Vitro Diagnostic Devices (OIVD)

Division Sign-Off   
Office of In Vitro Diagnostic Device   
Evaluation and Safety

# Indications for Use Form

510(k) Number (if known): _K103747

Device Name:

ELITech Clinical Systems CHOLESTEROL LDL SL 2G ELITech Clinical Systems CHOLESTEROL LDL 2G CALIBRATOR

Indications for Use:

# Reagent:

ELITech Clinical Systems CHOLESTEROL LDL SL 2G is intended for use with ELITech Clinical Systems CHOLESTEROL LDL 2G CALIBRATOR and ELITech Clinical Systems ELITROL I and ELITROL II for the quantitative in vitro diagnostic determination of Low Density Lipoprotein (LDL) Cholesterol in human serum and plasma on ELITech Clinical Systems Selectra analyzers. It is not intended for use in Point of Care settings.

Lipoprotein measurements are used in the diagnosis and treatment of lipid disorders (such as diabetes mellitus), atherosclerosis, and various liver and renal diseases.

# Calibrator:

ELITech Clinical Systems CHOLESTEROL LDL 2G CALIBRATOR is a calibrator for in vianstc calition  uantiv  nal CHOLESTEROL LDL SL 2G on ELITech Clinical Systems Selectra Analyzers.

(ciption Ue AND/OR (ver-The-CounteUuse)

(PLEASE DO NOT WRITE BELOW THIS LINE-CONTINUE ON ANOTHER PAGE OF NEEDED)

Concurrence of CDRH, Office of In Vitro Diagnostic Devices (OIVD)

Qutl Shast

Division Sign-Off   
Office of In Vitro Diagnostic Device   
Evaluation and Safety

# Indications for Use Form

510(k) Number (if known): _K103747 Device Name: ELITech Clinical Systems ELITROL I and ELITROL II

Indications for Use:

ELITech Clinical Systems ELITROL I & ELITROL II are multi-parametric control sera for in vitro diagnostic use in quality control of quantitative ELITech Clinical Systems methods on ELITech Clinical Systems Selectra analyzers.

# (PLEASE DO NOT WRITE BELOW THIS LINE-CONTINUE ON ANOTHER PAGE OF NEEDED)

Concurrence of CDRH, Offce of In Vitro Diagnostic Devices (OIVD)

Division Sign-Off   
Office of In Vitro Diagnostic Device   
Evaluation and Safety